Articles

Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations

Jungjin Kim, Eric MacMaster, Thomas L Schwartz

Article Type

Case Report

Published

Tardive dyskinesia (TD) can be a disfiguring side-effect of antipsychotic medications. In this article the authors review the risk of TD, the potential etiologic mechanisms and present some interesting cases of patients taking atypical antipsychotics who developed TD.

Read more

The non-anticoagulation costs of atrial fibrillation management: findings from an observational study in NHS Primary Care

George Kassianos, Chris Arden, Simon Hogan, Laura Baldock, Ahmet Fuat

Article Type

Original Research

Published

Atrial fibrillation (AF) management represents a significant burden on the UK NHS. In this article the authors review data from 825 patients in routine UK clinical practice and describe the non-anticoagulation costs associated with AF management. Understanding these costs better may help inform future health care planning and policy development.

Read more

Probabilistic data linkage: a case study of comparative effectiveness in COPD

Christopher M Blanchette, Mitch DeKoven, Ajita P De, Melissa Roberts

Article Type

Original Research

Published

In this era of comparative effectiveness research, new, advanced techniques are being investigated by the research community to overcome the limitations of existing data sources. In this article Dr Christopher Blanchette and his co-authors describe the approach of probabilistic data linkage as a means to address this critical issue.

Read more

Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries

Murat Altin, Ahmed A El-Shafei, Maria Yu, Durisala Desaiah, Tamas Treuer, Nikolay Zavadenko, Hong Yun Gao

Article Type

Original Research

Published

This prospective, observational, non-interventional study conducted in six non-Western countries concludes that after 12 months of treatment, clinical and functional outcomes were improved in children and adolescents with attention deficit hyperactivity disorder (ADHD) who initiated and remained on their prescribed pharmacological monotherapy.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.